The Great Prostate Hoax: How Big Medicine Hijacked the PSA Test and Caused a Public Health Disaster
Dr. Richard J. Ablin, professor of Pathology at the University of Arizona College of Medicine and discoverer of the prostate specific antigen (PSA) vehemently clarifies why he thinks routine screening of healthy men for prostate cancer using the PSA test is a profit-driven public health disaster.
Dr. Ablin along with science writer Ronald Piana brings forth an exposé on the PSA test, its FDA approval and a glimpse into the aftermath of its use for routine screening for detection of prostate cancer. The content is explosive with references to urologists, institutions, procedures, and excerpts from meeting transcripts.
The author unmasks the ways of the big biotech industry and takes to task men responsible for the national disaster that routine screening of PSA has brought about. He traces the PSA story with all details, from its discovery, through approval meetings of the Food and Drug Administration, into clinics of urologists, and stories of men who have had to endure unwarranted implications of the PSA screening viz. biopsies, surgeries, prostectomies, leading to incontinence, impotence, and other quality of life issues. He explains how and why the PSA test is not specific for cancer and explores options and answers for questions on why FDA approved a test which cites a 78% false-positive rate. Dr. Ablin unravels the motives behind the profit-driven biotech industry, expounding how the simple PSA test became part of the billion-dollar lies that sent thousands into the whirlwind of the ‘C’ world.
The book is extensively referenced and carries the reader through corridors and clinics of eminent institutions, prostate cancer awareness camps and world renowned prostate cancer experts at a thrilling pace which would make it difficult to put the book down.
A compelling read which would assuredly touch a chord and let your thoughts meander to those who have borne the brunt of it all. A must read for those connected with prostate cancer.